After treatment with the FDA-approved exon-skipping ASO, the patient-derived heart organoids attained the rhythmic activity seen in healthy organoids. Similar results were observed with an ASO ...
Less than a month after researchers unveiled that a “ticking DNA clock” is behind Huntington’s disease (HD), scientists have ...
Biogen will receive rights to commercialize zorevunersen outside the US, Canada, and Mexico, paying $165 million upfront and other milestone payments.
Biogen and Stoke Therapeutics have announced a partnership aimed at advancing a disease-modifying treatment for Dravet ...
8 天
The Brighterside of News on MSNScientists develop microcellular drones to deliver cancer-killing drugsLung cancer is one of the leading causes of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about ...
Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.
This course is part of The Applied Sciences of Oncology (ASO) distance-learning course.AimTo provide a practical understanding of applied anatomy relevant to the delivery of radiotherapy in the ...
Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance ...
During World War II, interest in the treatment only increased, and was part of training for armed service medical personnel. As with the lobotomy, the side effects of this practice came to be ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果